Progression of pancreatic intraductal neoplasias to infiltrating adenocarcinoma of the pancreas

American Journal of Surgical Pathology

Volumn 22, Issue 2, 1998, Pages 163-169

  Brat, Daniel J ^a   Lillemoe, Keith D ^a   Yeo, Charles J ^a   Warfield, Paul B ^b   Hruban, Ralph H ^a,c  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b Minnesota Gastroenterology   (United States)

^c JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Duct hyperplasia; Neoplasia; Pancreas; Pancreatic intraepithelial neoplasia; Pathology; Precursor

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INFILTRATION; CASE REPORT; CHRONIC PANCREATITIS; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; HYPERPLASIA; MALE; PANCREAS ADENOCARCINOMA; PANCREAS CARCINOMA; PANCREAS DUCT; PANCREAS RESECTION; PRECANCER;

ADENOCARCINOMA; AGED; FEMALE; HUMANS; HYPERPLASIA; MALE; MIDDLE AGED; PANCREAS; PANCREATIC NEOPLASMS;

EID: 0031891450     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000478-199802000-00003     Document Type: Article

References (37)

1. Berthelemy P, Bouisson M, Escourrou J, Vaysse N, Rumeau JL, Pradayrol L. Identification of K-ras mutations in pancreatic juice in the early diagnosis of pancreatic cancer. Ann Intern Med 1995; 123:188-91.
2. Bos JL, Fearon ER, Hamilton SR, Verlaan-de Vries M, van Boom JH, van der Eb AJ, Vogelstein B. Prevalence of ras gene mutations in human colorectal cancers. Nature 1987;327:293-7.
3. Boschman CR, Stryker S, Reddy JK, Rao MS. Expression of p53 protein in precursor lesions and adenocarcinoma of the human pancreas. Am J Pathol 1994;145:1291-5.
4. Brat DJ, Hahn SA, Griffin CA, Yeo CJ, Kern SE, Hruban RH. The structural basis of molecular genetic deletion. An integration of classical cytogenetic and molecular analyses in pancreatic adenocarcinoma. Am J Pathol 1997;150:383-91.
5. Brentnall TA, Chen R, Kimmey MB, et al. Ras mutations and microsatellite instability detected in ercp-derived pancreatic juice from patients with pancreatic cancer (Abstract). Gastroenterology 1995;108:452.
6. Caldas C, Hahn SA, da Costa LT, et al. Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma. Nat Genet 1994;8:27-32.
7. Caldas C, Hahn SA, Hruban RH, Redston MS, Yeo CJ, Kern SE. Detection of K-ras mutations in the stool of patients with pancreatic adenocarcinoma and pancreatic ductal hyperplasia. Cancer Res 1994;54:3568-73.
8. Carter D. Squamous cell carcinoma of the lung. An update. Semin Diagn Pathol 1985;2:226-34.
9. Cerny WL, Mangold KA, Scarpelli DG. K-ras mutation is an early event in pancreatic duct carcinogenesis in the Syrian golden hamster. Cancer Res 1992;52:4507-13.
10. Cubilla A, Fitzgerald PJ. Morphologic lesions associated with human primary invasive nonendocrine pancreas cancer. Cancer Res 1976;36:2690-2698.
11. Devesa SS, Young JL Jr, Brinton LA, Fraumeni JF Jr. Recent trends in cervix uteri cancer. Cancer 1989;64:2184-90.
12. DiGiuseppe JA, Hruban RH, Goodman SN, et al. Overexpression of p53 protein in adenocarcinoma of the pancreas. Am J Clin Pathol 1994;101:684-8.
13. DiGiuseppe JA, Hruban RH, Offerhaus GJA, Clement MJ, van den Berg FM, Cameron JL, van Mansfield ADM. Detection of K-ras mutations in mucinous pancreatic duct hyperplasia from a patient with a family history of pancreatic carcinoma. Am J Pathol 1994; 144:889-95.
14. DiGiuseppe JA, Yeo CJ, Hruban RH. Molecular biology and the diagnosis and treatment of adenocarcinoma of the pancreas. Adv Anat Pathol 1996;3:139-55.
15. Dupont WD, Page DL. Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med 1985;312:146-51.
16. Epstein JI. Pathology of prostatic intraepithelial neoplasia and adenocarcinoma of the prostate. Prognostic influences of stage, tumor grade, and margins of resection. Semin Oncol 1994;21:527-41.
17. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990;61:759-77.
18. Forrester K, Almoguera C, Han K, Grizzle WE, Perucho M. Detection of high incidence of K-ras oncogenes during human colon tumorigenesis. Nature 1987;327:298-303.
19. Fujii H, Inagaki M, Kasai S, et al. Genetic progression and heterogeneity in intraductal papillary-mucinous neoplasms of the pancreas. Am J Pathol 1997;151:1447-54.
20. Furukawa T, Chiba R, Kobari M, Matsuno S, Nagura H, Takahashi T. Varying grades of epithelial atypia in the pancreatic ducts of humans. Arch Pathol Lab Med 1994;118:227-34.
21. Hahn SA, Schutte M, Hoque ATMS, et al. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 1996;271:350-3.
22. Hameed M, Marrero AM, Conlon KC, Brennan MF, Klimstra DS. Expression of p53 nucleophosphoprotein in in situ pancreatic ductal adenocarcinoma: an immunohistochemical analysis of 100 cases[Abstract]. Lab Invest 1994;70:132.
23. Hamilton SR. Molecular genetics of colorectal carcinoma. Cancer 1992;70:1216-21.
24. Hruban RH, van der Riet P, Erozan YS, Sidransky D. Molecular biology and the early detection of carcinoma of the bladder - the case of Hubert H. Humphrey. N Engl J Med 1994;330:1276-8.
25. Hruban RH, van Mansfield ADM, Offerhaus GJA, et al. K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization. Am J Pathol 1993;143:545-54.
26. Johnson LD, Nickerson RJ, Easterday CL, Stuart RS, Hertig AT. Epidemiological evidence for the spectrum of change from dysplasia through carcinoma in situ to invasive cancer. Cancer 1968; 22:901-14.
27. Klimstra DS, Longnecker DS. K-ras mutations in pancreatic ductal proliferative lesions[Letter]. Am J Pathol 1994;45:1547-8.
28. Klöppel G, Heitz PU. Pancreatic Pathology. Edinburgh, Scotland: Churchill Livingstone, 1984.
29. Kozuka S, Sassa R, Taki T, et al. Relation of pancreatic duct hyperplasia to carcinoma. Cancer 1979;43:1418-28.
30. Moskaluk CA, Hruban RH, Kern SE. p16 and K-ras gene mutations in the intraductal precursors of human pancreatic adenocarcinoma. Cancer Res 1997;57:2140-3.
31. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics, 1997. CA Cancer J Clin 1997;47:5-27.
32. Piver MS. Invasive cervical cancer in the 1990's. Semin Surg Oncol 1990;6:359-63.
33. Tada M, Ohashi M, Shiratori Y, et al. Analysis of K-ras gene mutation in hyperplastic duct cells of the pancreas without pancreas disease. Gustroenterology 1996;110:227-31.
34. Vogelstein B, Fearon E, Hamilton SR, et al. Genetic alterations during colorectal-tumor development. N Engl J Med 1988;319: 525-32.
35. Yanagisawa A, Ohtake K, Ohahi K, et al. Frequent c-Ki-ras oncogene activation in mucous cell hyperplasias of pancreas suffering from chronic inflammation. Cancer Res 1993;53:953-6.
36. Yardley JH, Keren DF. "Precancer" lesions in ulcerative colitis. A retrospective study of rectal biopsy and colectomy specimens. Cancer 1974;34:835-44.
37. Yeo CJ, Cameron JL, Lillemoe KD, et al. Pancreatoduodenectomy for cancer of the head of the pancreas: 201 patients. Ann Surg 1995;221:721-33.